18 month study shows success of Acoustic CR® Neuromodulation in reducing tinnitus
In May this year, Dr Hannes Wurzer a leading ENT physician specialising in tinnitus in Germany presented the findings of an 18 month clinical study of Acoustic CR® Neuromodulation therapy as a poster at the International Tinnitus Seminar in Berlin. During 2011 and 2012, the 85 patients who took part in the study were assessed at […]
Survey of iPhone users: many people self manage their tinnitus
Between November 2019 and November 2022, the University of Michigan and Apple Inc. collaborated by surveying over 160,000 iPhone users in order to gain insights into contemporary tinnitus prevalence rates and symptom characteristics. Participants answered survey questions and completed app-based assessments to characterize their experience of tinnitus. This research aims to improve the understanding of […]
A new understanding of tinnitus and deafness could help reverse both | New Scientist
In this review of contemporary tinnitus research, the prominent academic, Will Sedley, summarises the recent advancements in the aetiological modelling of subject tinnitus and describes novel therapeutic approaches that may serve to reduce the severity of patient symptoms. The innovative Lenire® system is referenced within the article as a novel approach for the treatment of bothersome subjective tinnitus. […]
Lenire® tinnitus therapy – remarkable results
The Tinnitus Clinic Ltd. is the major provider of the innovative Lenire tinnitus therapy system within the UK. Lenire, the first and only CE and FDA approved tinnitus treatment device utilising bimodal (tactile and sound stimulation) and has been featured in the latest Textbook of Tinnitus:https://link.springer.com/book/10.1007/978-3-031-35647-6 You can read about Lenire’s “remarkable” clinical trial results […]
New hearing aid from Starkey – Genesis AI
The acclaimed hearing aid manufacturer Starkey Hearing Technologies has just launched their newest instrument platform Gensis AI in the UK. The Genesis AI features an advanced processor, a long-lasting rechargeable battery (51 hours from a single charge) along with an award-winning ergonomic shell design for improved wearing comfort. Genesis AI’s all-new Starkey Neuro Processor is […]
New hearing aid for people with tinnitus
The renowned hearing aid manufacturer Widex is in the process of commercialising a new type of hearing aid system that is specifically designed to help patients with tinnitus and milder hearing losses. Patients with mild hearing loss whose main complaint is tinnitus may benefit from amplification, in order to reduce their tinnitus perception, but often […]
FDA Grants Lenire Tinnitus Treatment De Novo Approval
We are delighted to report that Neuromod Devices Ltd. has been granted approval by the Food and Drugs Administration (FDA) to supply the Lenire tinnitus therapy system to patients in the U.S. This is the first time that a bimodal neuromodulation system has ever been grated FDA approval for the treatment of subjective tinnitus and […]
Tinnitus symptoms following coronavirus (COVID-19)
Earlier this week a new study investigating the impact of long COVID was published by University College Cork (UCC)1. This study involved 988 participants with 90% of participants reporting that they still have not returned to their pre COVID level of health and that their current symptoms were not present prior to contracting the virus. […]
New onset tinnitus after coronavirus vaccination
In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine’s side effects has become an important global health concern. In the present study, researchers determined the proportion of patients who […]
New onset tinnitus after coronavirus vaccination
In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine’s side effects has become an important global health concern.
